Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12005057 Methods of treating ovarian cancer

Patent 12005057 was granted and assigned to Tesaro on June, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Tesaro

Current Assignee

Tesaro

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

120050570

Patent Inventor Names

Robert Martell0

Mary Lynne Hedley0

Date of Patent

June 11, 2024

Patent Application Number

159865360

Date Filed

May 22, 2018

Patent Citations

‌

US Patent 9580407 Regioselective N-2 arylation of indazoles

‌

US Patent 8071623 Amide substituted indazoles as poly(ADP-ribose)polymerase(PARP) inhibitors

‌

US Patent 8436185 Pharmaceutically acceptable salts of 2-{4-[(3

‌

US Patent 9738915 Biocatalytic transamination process

Patent Primary Examiner

CPC Code

Patent abstract

The present invention provides methods of administering a PARP inhibitor to a cancer patient.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12005057 Methods of treating ovarian cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API